What does it mean to compare two stocks in this page?

This page compares two stocks, Oscar Health (stock_1) and Selective Insurance Group (stock_2), by outlining their business models, recent financial performance, and market context. It presents data-driven insights in clear, neutral terms without recommending actions, helping readers understand similarities and differences between the companies.

How should I interpret 'underwriting profits' for insurance stocks like stock_2?

Underwriting profit measures how much money an insurer makes from core insurance activities after claims and costs. For stock_2, a history of underwriting profits suggests a stabilised risk approach and disciplined pricing. Compare this with Oscar Health’s revenue growth and profitability challenges to gauge different business models.

What does a high beta imply for stock_1 and stock_2?

A high beta indicates greater price volatility relative to the overall market. For stock_1, the beta above 1.8 signals sensitivity to market swings, potentially amplifying gains and losses. For stock_2, if not stated, consider general market exposure; compare with stock_1 to assess two different risk profiles.

How should I weigh growth versus profitability when comparing these stocks?

Oscar Health emphasises revenue growth and scale, with profitability currently negative. Selective emphasises underwriting profitability and a stable balance sheet. When comparing, consider whether you prioritise revenue momentum (stock_1) or earnings stability (stock_2) and how each aligns with your risk tolerance.

What does a negative price-to-earnings ratio indicate in this context?

A negative trailing P/E ratio, as seen with stock_1, suggests the company is not currently profitable on a GAAP basis. It reflects ongoing losses and can signal higher risk or longer-term turnaround potential. Compare with stock_2, which may display positive earnings signals from underwriting profits.

How can I assess growth prospects using the provided data?

Look at projected revenue growth for stock_1, which analysts expect to rise markedly by 2027, alongside a recent lower SG&A ratio indicating efficiency gains. For stock_2, focus on its diversified business mix and stable underwriting. Use these signals to weigh growth potential against profitability and risk.

What do ‘market context’ and sector headwinds tell me here?

Market context refers to how broader conditions affect both stocks. The insurance sector can experience volatility from macroeconomic shifts and weather-related losses (especially for stock_2). Oscar Health faces growth challenges in a competitive healthcare market, influencing overall sentiment and pricing dynamics.

Why might analyst sentiment differ between stock_1 and stock_2?

Analysts may price Oscar Health as more speculative due to ongoing losses and a high-growth trajectory, leading to bearish sentiment. In contrast, stock_2’s underwriting profitability and balance sheet strength could support comparatively steadier sentiment. Divergent risks drive differing opinions.

How should a beginner use this page to compare risks?

Begin by noting each stock’s primary strength: stock_1’s revenue growth potential and high volatility, stock_2’s underwriting profitability and balance sheet. Consider risks such as profitability for stock_1 and reserve volatility for stock_2. Use the contrasts to form a balanced view rather than a buy/sell decision.

Is it safe to rely on the provided pros and cons for decision making?

The pros and cons summarise forward-looking statements and current performance signals but are not a substitute for independent analysis. They highlight strengths and risks for stock_1 and stock_2, helping readers form questions for further research rather than concrete conclusions.

Educational disclaimer: does this page provide financial advice?

No. The page is educational, aiming to clarify business models, financial performance, and market context for stock_1 and stock_2. It does not constitute financial advice or recommendations to buy or sell any securities. Readers should conduct their own research or consult a professional.

Oscar Health vs Selective

Oscar Health bets its future on tech-driven health insurance for individuals while Selective Insurance has spent over a century quietly compounding in the commercial property-casualty market. Both operate within the broader insurance industry, but their risk profiles, customer bases, and growth trajectories are miles apart. The Oscar Health vs Selective comparison reveals which insurer delivers more compelling financials and whether Oscar's disruptive model can match Selective's proven underwriting discipline.

Comparison Snapshot

Key Financial Metrics

OSCR

Metric

SIGI

$4.95B

Market Cap

$5.05B

-4.76%

Potential Profit

3.24%

Hold

Analyst Rating

Hold

Discover More Comparisons

Oscar Health vs Upstart

Oscar Health sells individual and small-group health insurance plans powered by its own technology platform while Upstart uses AI to underwrite personal and auto loans at a pace that traditional lenders can't match, pairing two data-driven financial platforms that took very different paths through the rising-rate environment. Both companies raised capital aggressively during low-rate conditions and had to reckon sharply with investor skepticism when macro conditions shifted. Oscar Health vs Upstart lays out the loss ratio trends, unit economics evolution, and path to sustainable profitability that define whether either company's growth thesis has actually matured.

Oscar Health vs Lemonade

Oscar Health built a tech-forward health insurance platform targeting individual and small-group markets with a digital-first member experience, while Lemonade set out to reinvent property and casualty insurance with AI-driven claims processing and a B-Corp charitable giving model. Both are insurtech companies that raised enormous amounts of capital on the promise that technology could make insurance faster, cheaper, and less adversarial, yet both have faced hard questions about underwriting losses and the path to profitability. The Oscar Health vs Lemonade comparison puts two high-profile insurance disruptors side by side to see whose loss ratios, growth rates, and capital runway tell a more convincing story about eventual viability.

Oscar Health vs Lazard

Oscar Health is a tech-driven health insurer chasing profitability in the individual market, while Lazard is a century-old financial advisory firm monetizing relationships at the top of global M&A and restructuring. They're both navigating fee-intensive business models, but that's where the similarities end. The Oscar Health vs Lazard comparison breaks down how growth trajectory, margin structure, and revenue predictability differ across these two distinct financial services plays.

Investment Analysis

Oscar Health

OSCR

Pros

Oscar Health has demonstrated rapid revenue growth, with analysts forecasting sales to rise from $9.17 billion in 2024 to $13 billion by 2027.
The company achieved record operational efficiency, reporting its lowest SG&A ratio in history at 15.8% in recent quarters.
Membership base expanded 41% to around 2 million, reflecting strong retention and new enrolment momentum.

Considerations

Oscar Health remains unprofitable, with trailing twelve-month net income at -$244 million and a negative price-to-earnings ratio.
Analyst sentiment is bearish, with an average rating of 'Sell' and a 12-month price target below the current share price.
The stock is highly volatile, with a beta above 1.8, indicating greater sensitivity to market swings than the average stock.

Selective

SIGI

Pros

Selective Insurance maintains a strong underwriting track record, consistently generating underwriting profits in recent years.
The company has a solid balance sheet, with high credit ratings and prudent capital management supporting financial stability.
Selective benefits from a diversified business mix, with exposure to both commercial and personal insurance lines across multiple regions.

Considerations

Growth in premiums has been modest compared to some peers, with limited expansion in new markets or product lines recently.
The company faces ongoing exposure to property and casualty insurance risks, including weather-related losses and reserve volatility.
Selective's stock has underperformed broader market indices over the past year, reflecting sector headwinds and valuation pressures.

Related Market Insights

When the Economy Wobbles, These Stocks Stand Firm

Navigate economic uncertainty with defensive stocks. Discover resilient companies in essential services & consumer staples for stability when markets turn choppy.

Aimee Silverwood | Financial Analyst

August 4, 2025

Read Insight

Related Market Insights

When the Economy Wobbles, These Stocks Stand Firm

Navigate economic uncertainty with defensive stocks. Discover resilient companies in essential services & consumer staples for stability when markets turn choppy.

Aimee Silverwood | Financial Analyst

August 4, 2025

Read Insight

About Oscar Health and Selective

Oscar Health (OSCR)

Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.

Selective (SIGI)

Selective Insurance Group, Inc. (SIGI) is a US-based property & casualty insurer that focuses on niche commercial lines and select personal lines distributed primarily through independent agents and brokers. The company targets small-to-medium commercial risks such as contractors, habitational and mercantile businesses, aiming to combine disciplined underwriting with targeted product offerings. Key value drivers for investors include underwriting margins, reserve development, catastrophe losses and investment income from a fixed-income portfolio. With a market capitalisation near $5.11bn, SIGI sits in the mid-cap insurer space where execution and pricing power can materially affect returns. Strengths can include established agent relationships and a focused regional footprint; risks include exposure to severe weather events, claim-cost inflation and competitive pricing. Shares can be volatile and dividends are dependent on operating results and capital needs. This is general educational information and not personalised investment advice — suitability depends on your goals, timeframe and risk tolerance.

Which Baskets Do They Appear In?

Defensive Plays For A Slowing Economy

U.S. job growth has slowed more than expected, signaling that economic uncertainty from trade tensions is impacting the labor market. This creates a potential investment opportunity in companies that are resilient to economic headwinds, such as those in defensive sectors and essential business services.

Published: August 4, 2025

Explore Basket

Which Baskets Do They Appear In?

Defensive Plays For A Slowing Economy

Published: August 4, 2025

Explore Basket

Buy OSCR or SIGI in Nemo

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Oscar Health vs Selective

Comparison Snapshot